The AKT inhibitor market is experiencing rapid growth, driven by the increasing demand for targeted therapies in cancer treatment. AKT inhibitors block the AKT protein, which plays a key role in cancer cell survival, proliferation, and metabolism. These drugs are particularly effective in treating cancers such as breast, prostate, and lung cancers, where the AKT signaling pathway is often...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian